Warfarin is associated with higher rates of upper gastrointestinal (GI) bleeding but not overall or lower gastrointestinal bleeding rates compared with direct oral anticoagulants (DOACs), according to ...

This newer mode of administration for immunotherapy comes with benefits and risks. It is important for a person to work with a doctor when making treatment decisions for upper gastrointestinal (GI) ...

Key opinion leaders navigate unmet needs across the treatment landscape of gastroesophageal cancer. Laura Bobolts, PharmD, BCOP: The unmet need for patients with esophageal and upper–GI ...

Laura Bobolts, PharmD, BCOP, shares her perspective surrounding cost-effective analyses surrounding GI and esophageal cancers. Laura Bobolts, PharmD, BCOP: From a payer’s perspective, it’s difficult ...

In patients discharged after hospitalization for nonvariceal upper gastrointestinal (GI) bleeding, cigarette smoking is associated with a significantly increased risk for readmission for recurrent ...

Please provide your email address to receive an email when new articles are posted on . Evidence for metoclopramide use in upper GI bleeding is very low, with few published trial data. Existing data ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted clearance to Medtronic’s endoscopic hemostasis system, Nexpowder, intended to improve visibility ...

In a recent study published in The Lancet Gastroenterology and Hepatology, researchers estimated the lifetime risk of gastrointestinal cancer and associated mortality. Study: Global, regional, and ...

Upper gastrointestinal involvement in CD appears uncommon and generally does not require different immunosuppressive treatment strategies. Response and remission rates to immunosuppressive therapy was ...

Elimination diets are frequently used to manage gastrointestinal symptoms, such as abdominal pain, bloating, nausea, constipation, and diarrhea, which do not have an organic explanation. The most ...